Mental Health

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

BrainsWay's strategic investment in BrainStim aims to expand Deep TMS access in Canada, targeting veterans and first responders with advanced mental health care.

A $3M grant from Lilly Endowment will empower Hope For The Warriors to expand evidence-based care and secure its future for military families nationwide.

Fueled by local pilot successes, over half of U.S. states are now considering guaranteed income laws, sparking a national debate on the future of work and welfare.

As a new report reveals staggering caregiver burnout, a new partnership offers micro-mindfulness tools. But is it enough to stem this silent epidemic?

With a donation of 50,000+ essentials, Ergobaby and its partners Baby2Baby and California hospitals are providing critical support to vulnerable families.

A new survey shows 77% of Americans embrace AI in behavioral health, but only with strict transparency, strong safeguards, and a doctor in the loop.

A new cancer care company has tapped titans of medicine, policy, and patient advocacy to guide its mission of transforming treatment from the clinic to the home.

New Directions Mental Health adds cutting-edge Spravato and TMS therapies, expanding access for Pennsylvanians with treatment-resistant depression.

Immigration Minister Diab is set to announce major changes to Canada's skilled worker program, targeting key labor shortages and reshaping the path to PR.

Chamber of Mothers and SmartyPants Vitamins launch a national program to rebuild community support for mothers facing unprecedented levels of isolation.

A new podcast from Understood.org and the Davos Neurodiversity Summit elevates neurodivergent voices, turning a global economic forum into a stage for inclusion.

Pioneering surgeon Dr. Gopal H. Badlani receives a top honor for his decades of work building sustainable urological care in underserved nations.

A new book introduces a controversial but promising treatment that reframes trauma as a physical injury, offering a biological 'reset' for the nervous system.

A new collaborative is launching major health services, from maternal care to mental health, to address deep-seated disparities on Chicago's Far Southside.

Neurotech leader BrainsWay adjusts its share structure in a move to enhance liquidity, clarify valuation, and attract a broader base of global investors.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

With a key depression drug nearing Phase 3 and more data imminent, AtaiBeckley is set to make its case to Wall Street at three major March conferences.

Landmark Phase 3 trial results show psilocybin offers rapid, lasting relief for severe depression, pushing psychedelic medicine closer to the mainstream.

A new health tech company has assembled a star-studded scientific board to back its AI-powered dementia prevention app. But can it deliver on its promise?